# Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers

> **NCT02480296** · PHASE1 · COMPLETED · sponsor: **MyoKardia, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MYK-461
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02480296
- **Lead sponsor:** MyoKardia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02480296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02480296, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT02480296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*